Researchers tested VER-01, a cannabis-based extract, on 820 adults with long-term lower back pain.
Patients who received VER-01 reported notable relief, stronger than the placebo group’s modest improvement.
Many also recorded better sleep and increased mobility after months of treatment.
Results Show Measurable Benefits Without Dependence
After three months, VER-01 users lowered pain scores by 1.9 points, compared with 0.6 points for placebo.
By six months, they showed further reductions and improved quality of life.
Reported side effects included mild dizziness, nausea, and drowsiness, but no signs of abuse or dependency emerged.
Experts Urge Caution Despite Encouraging Data
VER-01 contains controlled amounts of THC and other plant compounds, making it distinct from recreational cannabis.
Researchers emphasized patients should not self-medicate with marijuana, as smoking remains medically unsafe and ineffective.
Specialists stressed that more trials must compare VER-01 directly against opioids and other standard treatments.
Jan Vollert from the University of Exeter called the findings promising but warned against premature conclusions.
He noted the extract’s effects differ entirely from smoking cannabis, underscoring its potential medical value.
